Last reviewed · How we verify
Dose Response Trial of Biosynthetic Authentic Human Growth Hormone and Induction of Puberty With 17b Oestradiol in Girls With Turner's Syndrome
This trial is conducted in Europe. The aim of this trial is to assess whether increasing doses of somatropin (Norditropin®) can maintain the initial increase in height velocity and improve final height. This trial has two trial periods, a main period of 4 years and an extension period until final height is reached.
Details
| Lead sponsor | Novo Nordisk A/S |
|---|---|
| Phase | Phase 4 |
| Status | COMPLETED |
| Enrolment | 65 |
| Start date | 1989-11 |
| Completion | 2003-09 |
Conditions
- Genetic Disorder
- Turner Syndrome
Interventions
- somatropin
- somatropin
- somatropin
- oestrogen
Primary outcomes
- Final height
Countries
Netherlands